CXS 0.00% 70.0¢ chemgenex pharmaceuticals ltd

7-1 thumbs down - more testing needed, page-2

  1. 550 Posts.
    I think this is not a bad result. They are seeking from CXS that a generic diagnostic test be developed before approval is given so that patients can be accurately identified with the mutation.

    I always thought that a diagnostic test would be needed anyway to roll Omapro out.
 
watchlist Created with Sketch. Add CXS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.